Lactimidomycin is a potent inhibitor of eukaryotic translation elongation, exhibiting strong anti-proliferative effects against various cancer cell lines and selective inhibition of protein synthesis (IC50 = 37.82 nM); it also demonstrates potent and non-toxic antiviral activity against Dengue virus type 2 (DENV2) and other RNA viruses by inhibiting viral translation and reducing the production of infectious viral particles; in vivo, it significantly suppresses tumor growth in xenograft mouse models.